A new high frequency electrostimulation device to treat chronic prostatitis.

Area of Science:

• Urology
• Pain Management
• Medical Devices

Background:

• Chronic pelvic pain syndrome (CPPS) affects numerous men, with noninflammatory Category IIIB CPPS presenting a therapeutic challenge.
• Current treatment options for CPPS Cat IIIB may have limited efficacy or significant side effects.

Purpose of the Study:

• To evaluate the efficacy of a novel urethro-anal high-frequency electrostimulation device as a treatment for noninflammatory CPPS Cat IIIB.
• To assess the safety and tolerability of this new electrostimulation therapy.

Main Methods:

• A prospective study involving 14 male patients diagnosed with CPPS Cat IIIB.
• Patients received urethro-anal electrostimulation twice weekly for 5 weeks.
• Symptom severity and quality of life were measured using the National Institutes of Health (NIH) Prostatitis Symptom Score and a quality of life index before and after treatment.

Main Results:

• All 14 patients completed the treatment without any reported complications.
• A significant improvement was observed in 83% of patients.
• The mean NIH Prostatitis Symptom Score decreased significantly (p=0.002), as did pain scores (p=0.002) and micturition complaints (p=0.007).
• Quality of life scores also showed significant improvement (p=0.003).

Conclusions:

• Urethro-anal high-frequency electrostimulation demonstrates significant therapeutic benefit for patients with CPPS Cat IIIB.
• The device is simple to use and can be self-administered, suggesting potential as an ambulatory treatment option.
• This modality represents a novel and effective approach for managing chronic pelvic pain in this patient population.